Chemical and Pharmaceutical Bulletin p. 1462 - 1469 (1992)
Update date:2022-08-04
Topics:
Iguchi
Iwamura
Nishizaki
Hayashi
Senokuchi
Kobayashi
Sakaki
Hachiya
Ichioka
Kawamura
A novel, highly cardioselective ultra short-acting β-blocker, ONO-1101, has been developed for application in the emergency treatment of tachycardia and better control of heart rate in surgery. This agent is approximately nine times more potent in β-blocking activity in vivo and eight times more cardioselective in vitro than esmolol. This β-blocking drug has a short duration of activity, enabling rapid recovery after cessation of administration if side effects occur. It can be used safely in patients suffering from acute heart disease and represents a major therapeutic advance in the treatment of heart disease.
View MoreShanghai Hanshare Industry Co.,Ltd.
Contact:86 21 20960688
Address:RM902-903,Building E, Wanda Plaza,No.26,Zhoukang Road, Pudong District, Shanghai, China
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Contact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Chengdu Chengnuo New-Tech Co., Ltd
Contact:0086-028-85749078
Address:4 Jiuyang road,Jiulong industrial port,Chengdu, China
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
Doi:10.1134/S1070428013050138
(2013)Doi:10.1016/S0040-4039(01)85496-4
(1976)Doi:10.1039/c4ra03254c
(2014)Doi:10.1002/hlca.19760590739
(1976)Doi:10.1246/bcsj.49.3193
(1976)Doi:10.1016/S0040-4039(00)88734-1
(1990)